BioXcel Therapeutics faces regulatory challenges after the FDA found inconsistencies in one of its clinical trial sites, jeopardizing the supplementary approval of its drug, IGALMI. BioXcel's ...

This is the second in a series of discussions with Mike Glass, owner of Orion Technical Solutions, on ensuring data integrity ...

Throughput, efficiency, and reproducibility are key concerns in laboratory studies. Advances in digital science solutions and automated technologies are driving recent improvements in lab results, ...

The present world of digital transformation, streamlining workflows, enhancing operational efficiencies, and eliminating paper demands connected workflows with fully integrated systems and equipment.

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. GenAI is also making a splash in software development and mobile applications. In fact, due ...

A new research report from Yale School of Medicine offers an up-close look at how biased artificial intelligence can affect clinical outcomes. The study focuses specifically on the different stages of ...

With the rise of smart supply chain infrastructures, there is a growing need for seamless data interoperability and data integrity to ensure efficient and secure supply chain operations. “Smart supply ...

BioXcel Therapeutics (NASDAQ:BTAI) fell ~58% pre-market Thursday even after announcing that its Phase 3 trial for Alzheimer’s candidate BXCL501 reached its main goal as investors reacted to its data ...

BURLINGTON, Mass.--(BUSINESS WIRE)--Precisely, the global leader in data integrity, today released new findings from a global survey of over 450 data and analytics professionals conducted in ...